Literature DB >> 15977225

Surveillance of acute hepatitis C in Cairo, Egypt.

Maha M El Gaafary1, Claire Rekacewicz, Amira Gamal Abdel-Rahman, Mohamed Farouk Allam, Mostafa El Hosseiny, Mohamed Abdel Hamid, Françoise Colombani, Yehia Sultan, Saeed El-Aidy, Arnaud Fontanet, Mostafa Kamal Mohamed.   

Abstract

Surveillance of acute hepatitis has been set up in two fever hospitals in Cairo to diagnose acute hepatitis C. Patients were categorized as definite acute hepatitis C with positive hepatitis C virus (HCV) RNA and without anti-HCV antibody, or probable acute hepatitis C with positive HCV RNA, positive anti-HCV antibody, alanine aminotransferase >/=4 times the upper limit of normal (ULN), and high risk parenteral exposure in the 1--3 months prior to the beginning of symptoms. From May to November 2002, 315 patients were recruited in the study. Of these, 115 (36.5%) had acute hepatitis A, 89 (28.3%) had acute hepatitis B, and 111 (35.2%) had non-A non-B acute hepatitis. Of the total with complete data (n=309), 12 (3.9%, 95% CI=2.0%-6.7%) had definite acute hepatitis C, and 11 (3.6%, 95% CI=1.8%-6.3%) had probable acute hepatitis C. In patients with definite acute hepatitis C, dental exposure (n=5) and intravenous drug use (n=2), were the only high risk procedures found in the 6 months prior to diagnosis. Five patients had no identifiable parenteral exposure. In conclusion, results from this study suggest that acute hepatitis C can be diagnosed by surveillance of acute hepatitis in hospital settings in Cairo and that minor community exposures contribute substantially to local HCV transmission. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15977225     DOI: 10.1002/jmv.20392

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  16 in total

1.  Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt.

Authors:  Amr S Soliman; Chu-Wei Hung; Alexander Tsodikov; Ibrahim A Seifeldin; Mohamed Ramadan; Dina Al-Gamal; Emily L Schiefelbein; Priyanka Thummalapally; Subhojit Dey; Kadry Ismail
Journal:  Hepatol Int       Date:  2010-08-19       Impact factor: 6.047

2.  Circulating plasmacytoid dendritic cells in acutely infected patients with hepatitis C virus genotype 4 are normal in number and phenotype.

Authors:  Hala Mansour; Melissa E Laird; Rasha Saleh; Armanda Casrouge; Noha Sharaf Eldin; Sherif El Kafrawy; Maha Hamdy; Jérémie Decalf; Brad R Rosenberg; Arnaud Fontanet; Mohammed Abdel-Hamid; Mostafa K Mohamed; Matthew L Albert; Mona Rafik
Journal:  J Infect Dis       Date:  2010-10-19       Impact factor: 5.226

3.  Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry.

Authors:  Elizabeth M Lehman; Amr S Soliman; Kadry Ismail; Ahmed Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Hesham El-Hamzawy; Christiana S Shoushtari; Mark L Wilson
Journal:  Hepatol Res       Date:  2007-11-27       Impact factor: 4.288

4.  Epidemiology of hepatitis C virus exposure in Egypt: Opportunities for prevention and evaluation.

Authors:  F DeWolfe Miller; Mahmoud S Elzalabany; Sara Hassani; Diego F Cuadros
Journal:  World J Hepatol       Date:  2015-12-08

Review 5.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

6.  Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus.

Authors:  Vincent Pedergnana; Mohamed Abdel-Hamid; Julien Guergnon; Amira Mohsen; Lénaïg Le Fouler; Ioannis Theodorou; Mostafa Kamal Mohamed; Arnaud Fontanet; Sabine Plancoulaine; Laurent Abel
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

7.  Viral hepatitis a to e in South mediterranean countries.

Authors:  Sanaa M Kamal; Sara Mahmoud; Tamer Hafez; Runia El-Fouly
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-02-10       Impact factor: 2.576

8.  Injection drug use is a risk factor for HCV infection in urban Egypt.

Authors:  Adela Paez Jimenez; Mostafa K Mohamed; Noha Sharaf Eldin; Hasnaa Abou Seif; Said El Aidi; Yehia Sultan; Nasr Elsaid; Claire Rekacewicz; Mostafa El-Hoseiny; May El-Daly; Mohamed Abdel-Hamid; Arnaud Fontanet
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

9.  Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a.

Authors:  Noha Sharaf Eldin; Soheir Ismail; Hala Mansour; Claire Rekacewicz; Moustafa El-Houssinie; Sherif El-Kafrawy; Saeed El Aidi; Mohamed Abdel-Hamid; Gamal Esmat; Stanislas Pol; Arnaud Fontanet; Mostafa K Mohamed
Journal:  PLoS One       Date:  2008-12-30       Impact factor: 3.240

10.  Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression.

Authors:  Amal Abdul-rasheed El-Moamly; Mohamed Aly El-Sweify; Rafiaa M Rashad; Esam M Abdalla; Mostafa M Ragheb; Mohamed M Awad
Journal:  Parasitol Res       Date:  2013-03-21       Impact factor: 2.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.